Top Drugs at Risk of Supply Shortages: Report

Key Takeaways

• 48% of top 100 drugs rely on single-country starting material
• Injectables comprise 63% of drugs flagged for supply risk
• Iran‑Jordan conflict threatens API shipments, raising freight costs
• IV fluid shortages could cascade across entire hospital formularies

Pulse Analysis

The USP’s vulnerable medicines assessment shines a light on a systemic fragility that predates the current geopolitical flare‑up. By mapping 100 high‑use drugs, the study shows that nearly half depend on a sole source for a key starting material, creating a single‑point failure risk. This upstream exposure is most acute for injectables, which already demand complex sterile manufacturing and tight logistics, making them disproportionately represented among the flagged products.

Clinicians are already feeling the pressure as shortages spread across critical care categories. ICU sedatives such as midazolam and rocuronium, life‑saving IV fluids like normal saline and dextrose, and opioid analgesics including morphine are all listed as active shortages. Because these agents are administered in time‑sensitive settings, substitution options are limited, raising the stakes for patient outcomes and hospital operational costs. The ripple effect of an IV fluid shortage, for example, can halt dozens of concurrent therapies, amplifying the clinical impact beyond a single drug.

Geopolitical turbulence compounds these supply chain weaknesses. The Iran‑Jordan conflict has disrupted air routes, forced detours around no‑fly zones, and driven up fuel prices, all of which inflate the cost and delay of temperature‑sensitive shipments. With the Strait of Hormuz closed, petroleum‑derived inputs for active pharmaceutical ingredients become scarcer, further tightening the supply chain. Industry leaders are now urged to diversify manufacturing footprints, increase on‑shore production capacity, and adopt advanced inventory analytics to gain earlier visibility and mitigate the risk of a cascade of shortages.